SCHEMBL16615765

SCHEMBL16615765

CC(O)[C@@H]1NC(=O)[C@@H](NC(=O)[C@@H](N)CO)CCC(=O)NCCCC[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc2ccccc2)C(N)=O)N(C)C(=O)[C@H](CO)NC1=O

nearest known ligand 0.42

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
STAT3 P40763 2/20 0.42
SSTR2 P30874 1/20 0.41
SSTR4 P31391 1/20 0.41
SSTR5 P35346 1/20 0.41
OPRM1 P35372 3/20 0.41
OPRD1 P41143 3/20 0.41
OPRK1 P41145 3/20 0.41
MC1R Q01726 1/20 0.41
CPB2 Q96IY4 1/20 0.40
SSTR1 P30872 2/20 0.40
SSTR3 P32745 1/20 0.40
REN P00797 2/20 0.39
CALCRL Q16602 1/20 0.39
SRC P12931 1/20 0.39
CPA1 P15085 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16615884 0.85 SSTR1 (0.43) STAT3SSTR2SSTR4SSTR5OPRM1
SCHEMBL16615755 0.84 STAT3 (0.43) STAT3SSTR2SSTR4SSTR5OPRM1
SCHEMBL16615868 0.84 MC1R (0.45) SSTR2SSTR4SSTR5OPRM1OPRD1
SCHEMBL16615904 0.83 SRC (0.48) STAT3SSTR2SSTR4SSTR5MC1R
SCHEMBL16691478 0.82 SRC (0.51) STAT3SSTR2SSTR4SSTR5MC1R
SCHEMBL16615594 0.82 MC1R (0.46) STAT3SSTR2SSTR4SSTR5OPRM1
SCHEMBL16615864 0.81 SSTR5 (0.50) SSTR2SSTR4SSTR5OPRM1OPRD1
SCHEMBL16691476 0.81 SRC (0.49) STAT3SSTR2SSTR4SSTR5SSTR1
SCHEMBL16615857 0.81 SSTR1 (0.43) SSTR2SSTR4SSTR5OPRM1OPRD1
SCHEMBL16691494 0.81 SRC (0.49) STAT3SSTR2SSTR4SSTR5MC1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015044900-A1 THERAPEUTIC IMMUNOMODULATING COMPOUNDS AURIGENE DISCOVERY TECHNOLOGIES LIMITED (IN) 2015-04-02 WO disclosed